Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

75.72
-0.5600-0.73%
Post-market: 75.800.0800+0.11%17:31 EST
Volume:10.98M
Turnover:834.09M
Market Cap:112.25B
PE:39.03
High:76.87
Open:76.10
Low:75.52
Close:76.28
52wk High:109.50
52wk Low:72.69
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.74
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.68%
ROA:5.76%
PB:4.80
PE(LYR):39.03

Loading ...

Goldman Sachs Adjusts Boston Scientific Price Target to $98 From $99, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Back on the Radar: Prior Picks Offer Fresh Opportunity -- Barrons.com

Dow Jones
·
Feb 18

Boston Scientific: BUY on WATCHMAN Growth Optionality and Favorable CHAMPION-AF Risk/Reward Setup

TIPRANKS
·
Feb 18

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 18

Boston Scientific’s OPTION-EMEA Trial Targets One-Stop AF and Stroke Protection

TIPRANKS
·
Feb 18

Boston Scientific: EP Market Growth Validated by Medtronic, Supporting Renewed Confidence in Buy Rating

TIPRANKS
·
Feb 18

Boston Scientific Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 18

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Neurocrine (NBIX) and Dexcom (DXCM)

TIPRANKS
·
Feb 17

Does Boston Scientific’s 2026 Double-Digit Sales Outlook and Leadership Shift Change The Bull Case For BSX?

Simply Wall St.
·
Feb 14

Boston Scientific to Participate in TD Cowen's 46th Annual Health Care Conference

Reuters
·
Feb 13

Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Feb 13

Analysts Offer Insights on Healthcare Companies: Soligenix (SNGX) and Boston Scientific (BSX)

TIPRANKS
·
Feb 12

Philips Consortium Secures EUR 23.5 Million IHI Grant for Minimally Invasive Brain Treatment Research

Reuters
·
Feb 11

Boston Scientific (BSX) Gets a Buy from BTIG

TIPRANKS
·
Feb 10

Boston Scientific Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

Boston Scientific Price Target Maintained With a $110.00/Share by BTIG

Dow Jones
·
Feb 10

Boston Scientific (BSX) Valuation Check After Earnings Strength And Softer Electrophysiology And Watchman Trends

Simply Wall St.
·
Feb 09

Boston Scientific: Multi-Year Double-Digit Growth Outlook Makes Share Pullback a Buy Opportunity

TIPRANKS
·
Feb 09

Boston Scientific: Durable Growth, Expanding EP Opportunity, and Upside-Skewed Valuation Justify Buy Rating

TIPRANKS
·
Feb 09

Bernstein Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Feb 06